Accordingly, we hypothesised that SIRT1 activation would reduce α cell hyperplasia and hyperglucagonaemia as a way of attenuating the insensible energy loss of hyperglycemia in type 1 diabetes. Here, SIRT1 is linked to type 1 diabetes mellitus.